<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695199461775</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>Vitamin C update - Recent study</TITLE>


<TEXT>
© The Urban Clinic 
        Of course, I am always   ahem   ahead of my time, but I just <EVENT eid="e1" class="OCCURRENCE">noted</EVENT> this study that <EVENT eid="e2" class="OCCURRENCE">came</EVENT> out very recently. It demonstrates that if you <EVENT eid="e3" class="OCCURRENCE">give</EVENT> Vitamin C (along with hydrocortisone and thiamine) for just over <TIMEX3 tid="t1" type="DURATION" value="P2D">two days</TIMEX3> in patients admitted with sepsis (blood poisoning) the mortality rate <EVENT eid="e4" class="STATE">falls</EVENT> from 40% to 8.5%. The mortality rate in low income countries is normally around 60%. 
Now, this was a small study, but it seems robust. It represents an almost five fold reduction in mortality, but I <EVENT eid="e5" class="I_STATE">think</EVENT> it provides some pretty strong support for the benefits of vitamin C. The conclusions of the study, repeated below were that. 
 
 Our results <EVENT eid="e6" class="I_STATE">suggest</EVENT> that the early use of intravenous vitamin C, together with corticosteroids and thiamine may prove to be <EVENT eid="e7" class="STATE">effective</EVENT> in <EVENT eid="e8" class="OCCURRENCE">preventing</EVENT> progressive organ dysfunction including acute kidney injury and <EVENT eid="e9" class="OCCURRENCE">reducing</EVENT> the mortality of patients with severe sepsis and septic shock.  
  Hydrocortisone, Vitamin C and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before After Study 
Paul E. Marik, MD, FCCM, FCCP; Vikramjit Khangoora, MD; Racquel Rivera, Pharm D; Michael H. Hooper, M.D., MSc; John Catravas, PhD, FAHA, FCCP 

Chest. <TIMEX3 tid="t2" type="DATE" value="2016">2016</TIMEX3>. doi:10.1016/j.chest.2016.11.036 

Abstract 

Background: The global burden of sepsis is <EVENT eid="e10" class="STATE">estimated</EVENT> as 15 to 19 million cases annually with a mortality rate approaching 60% in low income countries. 

Methods: In this <EVENT eid="e11" class="OCCURRENCE">retrospective</EVENT> before after clinical study, we <EVENT eid="e12" class="OCCURRENCE">compared</EVENT> the outcome and clinical course of consecutive septic patients <EVENT eid="e13" class="OCCURRENCE">treated</EVENT> with intravenous vitamin C, hydrocortisone and thiamine during a <TIMEX3 tid="t3" type="DATE" value="2017-Q1">7 month period</TIMEX3> (treatment group) compared to a control group <EVENT eid="e14" class="OCCURRENCE">treated</EVENT> in our ICU during the preceding <TIMEX3 tid="t4" type="DURATION" value="P7M">7 months</TIMEX3>. The primary outcome was hospital survival. A propensity score was <EVENT eid="e15" class="I_STATE">generated</EVENT> to <EVENT eid="e16" class="OCCURRENCE">adjust</EVENT> the primary outcome. 

Findings: There were 47 patients in both treatment and control groups with no significant differences in baseline characteristics between the two groups. The hospital mortality was 8.5% (4 of 47) in the treatment group compared to 40.4% (19 of 47) in the control group (p  <EVENT eid="e17" class="OCCURRENCE">lt</EVENT>; 0.001). The propensity adjusted odds of mortality in the patients treated with the vitamin C protocol was 0.13 (95% CI 0.04 0.48, p=002). The SOFA score <EVENT eid="e18" class="OCCURRENCE">decreased</EVENT> in all patients in the treatment group with none <EVENT eid="e19" class="OCCURRENCE">developing</EVENT> progressive organ <EVENT eid="e20" class="OCCURRENCE">failure</EVENT>. Vasopressors were <EVENT eid="e21" class="OCCURRENCE">weaned</EVENT> off all patients in the treatment group, a mean of 18.3 ± 9.8 hours after <EVENT eid="e22" class="OCCURRENCE">starting treatment</EVENT> with vitamin C protocol. The mean duration of vasopressor use was 54.9 ± 28.4 hours in the control group (p <EVENT eid="e23" class="OCCURRENCE">lt</EVENT>;0.001). 

Conclusion: Our results <EVENT eid="e24" class="I_STATE">suggest</EVENT> that the early use of intravenous vitamin C, together with corticosteroids and thiamine may prove to be <EVENT eid="e25" class="STATE">effective</EVENT> in <EVENT eid="e26" class="OCCURRENCE">preventing</EVENT> progressive organ dysfunction including acute kidney injury and <EVENT eid="e27" class="OCCURRENCE">reducing</EVENT> the mortality of patients with severe sepsis and septic shock. Additional studies are <EVENT eid="e28" class="I_STATE">required</EVENT> to <EVENT eid="e29" class="I_ACTION">confirm</EVENT> these preliminary findings.
</TEXT>


<MAKEINSTANCE eiid="ie19" eventID="e19" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="UNKNOWN" tense="PASTPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="UNKNOWN" tense="PRESPART" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="ADJECTIVE" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie24" eventID="e24" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie25" eventID="e25" pos="ADJECTIVE" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie26" eventID="e26" pos="UNKNOWN" tense="PRESPART" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie27" eventID="e27" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="NOUN" tense="NONE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie22" eventID="e22" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie23" eventID="e23" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie28" eventID="e28" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie29" eventID="e29" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />

<TLINK lid="TL1" eventInstanceID="ie15" relatedToEventInstance="ie16" relType="AFTER" />
<TLINK lid="TL0" eventInstanceID="ie19" relatedToEventInstance="ie20" relType="AFTER" />
<TLINK lid="TL2" eventInstanceID="ie20" relatedToEventInstance="ie19" relType="AFTER" />
</TimeML>
